Table 4.
Differences in odds of being on RASi or statin treatment at first eGFR measurement <60 ml/min per 1.73 m2 in the Stockholm region from 2009 to 2017, women compared with men
| Category | Proportion of Patients Treated | Odds (95% CI) of Receiving Guideline-Recommended Medications | |||||
|---|---|---|---|---|---|---|---|
| Number of Individuals | Men | Women | Unadjusted OR Women versus Men |
P Value | Adjusted ORa Women versus Men |
P Value | |
| RASi | |||||||
| Overall | 227,847 | 56.2% | 46.7% | 0.68 (0.67 to 0.69) | <0.001 | 0.68 (0.66 to 0.69) | <0.001 |
| Among people with diabetes and albuminuria A2 | 7688 | 81.2% | 76.6% | 0.72 (0.64 to 0.81) | <0.001 | 0.68 (0.59 to 0.77) | <0.001 |
| Among people with albuminuria A3 | 8506 | 78.2% | 66.4% | 0.60 (0.54 to 0.65) | <0.001 | 0.68 (0.61 to 0.76) | <0.001 |
| Statins | |||||||
| Overall | 227,847 | 38.2% | 28.8% | 0.65 (0.64 to 0.67) | <0.001 | 0.78 (0.76 to 0.79) | <0.001 |
| Among people aged ≥50 yrs | 217,384 | 39.6% | 29.7% | 0.64 (0.63 to 0.66) | <0.001 | 0.80 (0.78 to 0.82) | <0.001 |
| Among people aged 18–49 yr with | |||||||
| Coronary disease | 166 | 74.6% | 60.4% | 0.54 (0.27 to 1.09) | 0.09 | 0.41 (0.15 to 1.12) | 0.08 |
| Diabetes | 939 | 45.1% | 34.1% | 0.63 (0.48 to 0.82) | 0.001 | 0.74 (0.55 to 0.99) | 0.05 |
| Prior ischemic stroke | 174 | 46.4% | 33.9% | 0.62 (0.33 to 1.17) | 0.14 | 0.62 (0.27 to 1.42) | 0.26 |
a
Adjusted for age at creatinine measurement, albuminuria category (no test, albuminuria A1, A2, A3), eGFR, history of referral, KDIGO, Kidney Disease: Improving Global Outcomes (KDIGO) criteria for referral, highest educational attainment, hypertension, diabetes, myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic obstructive pulmonary disease, and malignancy.